Regeneron Acquires 23andMe in Bankruptcy Auction for $256 Million

by News Editor

May 19, 2025

Regeneron Pharmaceuticals has strategically acquired 23andMe, a genetic testing company, in a bankruptcy auction for $256 million. The purchase aims to blend pharmaceutical expertise with genetic insights, unlocking a new chapter for scientific exploration.

Regeneron has pledged to adhere to 23andMe’s stringent privacy policies concerning customer data, presenting their intentions to a court-appointed overseer.

Follow THE FUTURE on LinkedIn, Facebook, Instagram, X and Telegram

The bankruptcy filing in March had raised concerns among lawmakers regarding the privacy of genetic information belonging to over 15 million customers. In response, 23andMe consented to oversight of its data management practices.

Despite the data breach in 2023 and declining demand for their testing kits, 23andMe’s integration into Regeneron aims to drive innovation. Excluding Lemonaid Health, all 23andMe units will merge with Regeneron to continue as an autonomous entity.

The Future Forbes Realty Global Properties

CSE Reports March Market Shares As Argus Tops With 30.83%

by THEFUTURE.TEAM

April 7, 2026

Overview

Cyprus Stock Exchange (CSE) reported €31.50 million in share transactions for March 2026, including €11.24 million in pre-agreed trades. Data also cover the first quarter, with total transactions reaching €86.06 million across January to March.

Detailed Market Analysis

CSE provides market share calculations both including and excluding pre-agreed transactions. March figures incorporate these trades, while separate data sets highlight activity without them. Such differentiation reflects varying trading dynamics and offers a clearer view of market structure. Bond values are excluded from percentage calculations.

Follow THE FUTURE on LinkedIn, Facebook, Instagram, X and Telegram

Quarterly Performance Metrics

Figures for the January–March period show how market shares shift depending on the calculation methodology. Year-to-date data provide a broader perspective on member activity across the exchange. Inclusion or exclusion of pre-agreed transactions affects comparative positioning. These metrics are used to assess overall performance trends.

Key Participant Performance

Argus Stockbrokers Ltd recorded a 30.83% market share in March, with transactions totaling €9.71 million, placing it first for the month. CISCO Ltd held a 24.54% share in March and ranked first for the quarter with 26.19%. Mega Equity Financial Services Ltd followed with 18.31% in March and 24.08% across the quarter. Additional participants included Eurobank EFG Equities with 8.04% and Atlantic Securities Ltd with 7.46%, contributing to overall market activity.

Aggregate Trading Volumes

Pre-agreed transactions accounted for €11.24 million of March’s total turnover. Overall trading value reached €86.06 million for the first quarter. These figures reflect both negotiated and regular market activity, providing a fuller picture of trading volumes.

Conclusion

CSE data outline the distribution of market shares and transaction volumes across members. Distinctions between pre-agreed and regular trades highlight differences in activity patterns. Reported figures provide a basis for evaluating market structure and participant performance.

Breaking news